University Hospital, Clermont-Ferrand: Acute Lung Injury trials

The registry lists 11 Acute Lung Injury studies with University Hospital, Clermont-Ferrand as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 3 1Phase 4 1No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Inhaled Sevoflurane for ARDS PreventionRecruitingNCT05849779Phase 3
• Hemodynamic Effects of Two Modalities of Alveolar Recruitment Maneuvers - ICU PatientsStatus unknownNCT05365854Not applicable
• Effects of End-expiratory Positive Pressure Optimization in Intubated Patients With Healthy Lung or Acute Respiratory Distress SyndromeStatus unknownNCT04503876Not applicable
• Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19)CompletedNCT04383730
• Sevoflurane PharmacokInetics in ARDSTerminatedNCT04023305Not applicable
• A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical StudyCompletedNCT02545621
• Predictive Values of Plasma Soluble RAGE Levels and RAGE Polymorphisms for the Onset of Acute Respiratory Distress Syndrome in Critically Ill PatientsCompletedNCT02070536
• Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS)Status unknownNCT01763853Phase 4
• Soluble Forms and Ligands of RAGE in ALI/ARDS (SoLiRAGE).CompletedNCT01270295
• Impact of Inflammation Biomarkers on the Acute Respiratory Distress Syndrome (ARDS) DefinitionCompletedNCT01161901
• Influence of Acute Respiratory Distress Syndrome (ARDS) and Severe Sepsis on sRAGE Levels in ICU PatientsCompletedNCT00811629